Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053206 | 0.76 | PDE4A (0.46) | PDE3AALDH1A1PDE4APDE4BPDE4C | |
| SCHEMBL10053282 | 0.72 | PDE4A (0.34) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053203 | 0.72 | PDE4B (0.34) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL5583511 | 0.71 | CA1 (0.59) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500368 | 0.71 | CA1 (0.59) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053276 | 0.68 | CA1 (0.48) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL12589684 | 0.67 | CA1 (0.53) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL597009 | 0.67 | CA1 (0.49) | CA1CA2PDE3ACNR2PDE4A | |
| SCHEMBL13996402 | 0.65 | CA1 (0.44) | CA1CA2 | |
| SCHEMBL5583512 | 0.62 | CA1 (0.47) | CA1CA2PDE3APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106031-B2 | Hydrolytically-resistant boron-containing therapeutics and methods of use | ANACOR PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |